Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,863 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The NIH-led research response to COVID-19.
Collins F, Adam S, Colvis C, Desrosiers E, Draghia-Akli R, Fauci A, Freire M, Gibbons G, Hall M, Hughes E, Jansen K, Kurilla M, Lane HC, Lowy D, Marks P, Menetski J, Pao W, Pérez-Stable E, Purcell L, Read S, Rutter J, Santos M, Schwetz T, Shuren J, Stenzel T, Stoffels P, Tabak L, Tountas K, Tromberg B, Wholley D, Woodcock J, Young J. Collins F, et al. Among authors: hall m. Science. 2023 Feb 3;379(6631):441-444. doi: 10.1126/science.adf5167. Epub 2023 Feb 2. Science. 2023. PMID: 36730407
A call to action for translational sciences in COVID-19 and future pandemics.
Wan KK, Davis D, Lee TN, Ford-Scheimer SL, Andreu AL, Bietrix F, Bryans J, Castro MT, Chiba N, Faupel-Badger JM, Haynes B, Hirasawa R, Morel CM, Souza TML, Morrow D, Munro T, Newman S, Ussi AE, Zorzal PB, Hall MD, Lo DC, Cutillo CM. Wan KK, et al. Among authors: hall md. Nat Rev Drug Discov. 2022 Mar;21(3):165-166. doi: 10.1038/d41573-022-00020-6. Nat Rev Drug Discov. 2022. PMID: 35091700 No abstract available.
The Fundamental Characteristics of a Translational Scientist.
Gilliland CT, White J, Gee B, Kreeftmeijer-Vegter R, Bietrix F, Ussi AE, Hajduch M, Kocis P, Chiba N, Hirasawa R, Suematsu M, Bryans J, Newman S, Hall MD, Austin CP. Gilliland CT, et al. Among authors: hall md. ACS Pharmacol Transl Sci. 2019 May 2;2(3):213-216. doi: 10.1021/acsptsci.9b00022. eCollection 2019 Jun 14. ACS Pharmacol Transl Sci. 2019. PMID: 32259057 Free PMC article.
Comparative evaluation of outcomes amongst different radiosurgery management paradigms for patients with large brain metastasis.
Kutuk T, Zhang Y, Akdemir EY, Yarlagadda S, Tolakanahalli R, Hall MD, La Rosa A, Wieczorek DJ, Lee YC, Press RH, Appel H, McDermott MW, Odia Y, Ahluwalia MS, Gutierrez AN, Mehta MP, Kotecha R. Kutuk T, et al. Among authors: hall md. J Neurooncol. 2024 Jun 5. doi: 10.1007/s11060-024-04706-2. Online ahead of print. J Neurooncol. 2024. PMID: 38837019
Epinephrine Dosing Intervals Are Associated With Pediatric In-Hospital Cardiac Arrest Outcomes: A Multicenter Study.
Kienzle MF, Morgan RW, Reeder RW, Ahmed T, Berg RA, Bishop R, Bochkoris M, Carcillo JA, Carpenter TC, Cooper KK, Diddle JW, Federman M, Fernandez R, Franzon D, Frazier AH, Friess SH, Frizzola M, Graham K, Hall M, Horvat C, Huard LL, Maa T, Manga A, McQuillen PS, Meert KL, Mourani PM, Nadkarni VM, Naim MY, Pollack MM, Sapru A, Schneiter C, Sharron MP, Tabbutt S, Viteri S, Wolfe HA, Sutton RM. Kienzle MF, et al. Among authors: hall m. Crit Care Med. 2024 Jun 4. doi: 10.1097/CCM.0000000000006334. Online ahead of print. Crit Care Med. 2024. PMID: 38833560
A Randomized Controlled Clinical Trial Testing Effects of Lademirsen on Kidney Function Decline in Adults with Alport Syndrome.
Gale DP, Gross O, Wang F, Esteban de la Rosa RJ, Hall M, Sayer JA, Appel G, Hariri A, Liu S, Maski M, Shen Y, Zhang Q, Iqbal S, Kowthalam MU, Lin J, Ding J; HERA Clinical Trial Group. Gale DP, et al. Among authors: hall m. Clin J Am Soc Nephrol. 2024 Jun 3. doi: 10.2215/CJN.0000000000000458. Online ahead of print. Clin J Am Soc Nephrol. 2024. PMID: 38829703
Establishment of human post-vaccination SARS-CoV-2 standard reference sera.
Xiang J, Katz L, Winokur PL, Chaudhary A, Digmann B, Bradford R, Rashid S, Ghosh S, Robertson A, Menetski J, Xu M, Gao P, Chen CZ, Lee T, Poelaert B, Eastman RT, Hall MD, Stapleton JT. Xiang J, et al. Among authors: hall md. J Immunol Methods. 2024 May 31;530:113698. doi: 10.1016/j.jim.2024.113698. Online ahead of print. J Immunol Methods. 2024. PMID: 38823574
Phase Ib trial of IRX-2 plus durvalumab in patients with recurrent and/or metastatic head and neck squamous cell carcinoma.
Park R, Li J, Slebos RJC, Chaudhary R, Poole MI, Ferraris C, Farinhas J, Hernandez-Prera J, Kirtane K, Teer JK, Song X, Hall MS, Tasoulas J, Amelio AL, Chung CH. Park R, et al. Among authors: hall ms. Oral Oncol. 2024 May 30;154:106866. doi: 10.1016/j.oraloncology.2024.106866. Online ahead of print. Oral Oncol. 2024. PMID: 38820888
6,863 results